ATE74126T1 - D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum. - Google Patents

D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum.

Info

Publication number
ATE74126T1
ATE74126T1 AT88300710T AT88300710T ATE74126T1 AT E74126 T1 ATE74126 T1 AT E74126T1 AT 88300710 T AT88300710 T AT 88300710T AT 88300710 T AT88300710 T AT 88300710T AT E74126 T1 ATE74126 T1 AT E74126T1
Authority
AT
Austria
Prior art keywords
prostaglandins
tranquilizers
hypnotics
applications
soporifics
Prior art date
Application number
AT88300710T
Other languages
German (de)
English (en)
Inventor
Ryuzo Ueno
Ryuji Ueno
Ichie Kato
Tomio Oda
Original Assignee
Ueno Seiyaku Oyo Kenkyujo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo Kk filed Critical Ueno Seiyaku Oyo Kenkyujo Kk
Application granted granted Critical
Publication of ATE74126T1 publication Critical patent/ATE74126T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AT88300710T 1987-01-28 1988-01-28 D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum. ATE74126T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1882187 1987-01-28
EP88300710A EP0281239B1 (en) 1987-01-28 1988-01-28 Prostaglandins of the d series, and tranquilizers and soporifics containing the same

Publications (1)

Publication Number Publication Date
ATE74126T1 true ATE74126T1 (de) 1992-04-15

Family

ID=11982228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88300710T ATE74126T1 (de) 1987-01-28 1988-01-28 D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum.

Country Status (8)

Country Link
US (3) US5073569A (enExample)
EP (1) EP0281239B1 (enExample)
KR (1) KR930006201B1 (enExample)
AT (1) ATE74126T1 (enExample)
CA (1) CA1322749C (enExample)
DE (1) DE3869444D1 (enExample)
ES (1) ES2032956T3 (enExample)
GR (1) GR3004281T3 (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.
JP2597629B2 (ja) 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP1348437A3 (en) * 1988-09-06 2003-11-19 Pharmacia Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE122563T1 (de) * 1989-07-27 1995-06-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
EP0415564B1 (en) * 1989-08-09 1995-04-26 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Use of prostanoic acid derivaties for the manufacture of a medicament for improvement of excretion of nonprotein nitrogen into the intestine
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
TW224942B (enExample) * 1990-04-04 1994-06-11 Adka Ueno Kk
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ES2093774T3 (es) * 1991-03-14 1997-01-01 R Tech Ueno Ltd Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
DE69912277T2 (de) 1998-05-25 2004-07-15 Taisho Pharmaceutical Co., Ltd. Prostaglandinderivate
CA2403086C (en) 2000-03-24 2010-08-17 Sucampo Ag Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof
JP4183943B2 (ja) 2000-04-06 2008-11-19 スキャンポ・アーゲー １５−ケトプロスタグランジンを含む胆汁分泌促進剤組成物
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
AU2002330747B2 (en) 2001-08-31 2007-07-19 Sucampo Ag Prostaglandin analogs as chloride channel opener
EP1562604B1 (en) * 2002-10-23 2012-01-04 Sucampo AG Prostaglandin compounds for the treatment of obesity
AU2003292556B2 (en) 2002-12-27 2009-09-10 Sucampo Ag Derivatives of prostaglandins for treating abdominal discomfort
US8337891B2 (en) * 2003-07-03 2012-12-25 Sucampo Ag Enteric coated composition comprising prostaglandin analogs as chloride channel opener
TWI495471B (zh) * 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
KR20120005052A (ko) 2003-08-21 2012-01-13 수캄포 아게 안과용 조성물
US7321057B2 (en) * 2004-08-02 2008-01-22 R-Tech Ueno, Ltd. Method for manufacturing prostaglandin analogue
AU2006209072B2 (en) 2005-01-27 2011-02-24 Sucampo Ag Method and composition for treating central nervous system disorders
US8143316B2 (en) 2005-03-04 2012-03-27 Sucampo Ag Method for treating peripheral vascular diseases
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
EP1871380B1 (en) * 2005-04-12 2011-10-19 Sucampo AG Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
CA2637275C (en) 2006-01-24 2014-12-09 R-Tech Ueno, Ltd. Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
RU2420291C3 (ru) * 2006-01-24 2020-07-21 Р-Тек Уено, Лтд. Состав в мягкой желатиновой капсуле
CA2645311C (en) 2006-03-13 2014-11-18 R-Tech Ueno, Ltd. Aqueous composition comprising 15-keto-prostaglandin for ophthalmic use
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
US8609729B2 (en) 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
US8569279B2 (en) * 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
WO2012137987A1 (en) 2011-04-07 2012-10-11 Sucampo Ag Method for treating asthenopia
AU2012293157A1 (en) * 2011-08-05 2014-03-13 Sucampo Ag Method for treating schizophrenia
AR092821A1 (es) 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
US20150057351A1 (en) 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain
US20170020890A1 (en) 2015-06-19 2017-01-26 Sucampo Ag Pharmaceutical composition comprising fatty acid derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476661A (en) * 1974-05-13 1977-06-16 American Cyanamid Co Prostaglandins
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.

Also Published As

Publication number Publication date
ES2032956T3 (es) 1993-03-01
GR3004281T3 (enExample) 1993-03-31
US5534547A (en) 1996-07-09
US5137915A (en) 1992-08-11
EP0281239B1 (en) 1992-03-25
EP0281239A3 (en) 1988-09-21
EP0281239A2 (en) 1988-09-07
KR880008986A (ko) 1988-09-13
DE3869444D1 (de) 1992-04-30
US5073569A (en) 1991-12-17
KR930006201B1 (ko) 1993-07-08
CA1322749C (en) 1993-10-05

Similar Documents

Publication Publication Date Title
DE3869444D1 (de) D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum.
DE69009636D1 (de) Belastungsregelung und Verfahren.
DE3884095D1 (de) Polymerteilchen und ihre Herstellung.
DE3851132D1 (de) Polymerteilchen und ihre Herstellung.
DE3884453D1 (de) Homogene additionscopolymere von ethylen und cycloolefinmonomeren und deren herstellung.
DE3853340D1 (de) Dien-Blockpolymer und Polymerzusammensetzung.
DE3789761D1 (de) Reibungsmaterialien und Herstellung derselben.
ATE82574T1 (de) Bis-aza-bicyclische anxiolytica und antidepressiva.
DE3888146D1 (de) Modifizierte Polytetrafluoräthylenharze und damit hergestellte Zusammensetzungen.
DE3882392D1 (de) Kondensations-copolymere, die farbstoffe des typs 2,5-diarylaminoterephthalsaeure enthalten und produkte daraus.
DE3767400D1 (de) Biozide zusammensetzungen und deren verwendung.
DE69010141D1 (de) Lager und Lageranordnung.
DE3873797D1 (de) E-prostaglandine und ihre anti-ulcusanwendung.
DE3879811D1 (de) Pharmazeutische zusammensetzung und ihre verwendung.
DE68917352D1 (de) Trimethylolheptane und ihre Anwendung.
DE69002520D1 (de) Azeotropaehnliche zusammensetzungen von 1,1-dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1-fluoraethan.
PT85396B (de) Neue 1,4-benzodiazepine ihre herstellung und verwendung
DE3766441D1 (de) Anilinotriazine und deren verwendung.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DE69012298D1 (de) Heizen von Lagern und dergleichen.
DE69011337D1 (de) Polyhalodihydrodioxine und polyhalodioxole.
ES2044100T4 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
DE59003130D1 (de) Mikrobizid-Formulierungen und deren Verwendung.
DE3875199D1 (de) Dispergiermittel und dieses enthaltende feststoffsuspension.
DE3880307D1 (de) Perfluoralkene und fluorierungsprodukte davon.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee